Endogenous IL-6 of mesenchymal stem cell improves behavioral outcome of hypoxic-ischemic brain damage neonatal rats by supressing apoptosis in astrocyte

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Gu, Yan ^a   He, Mulan ^a   Zhou, Xiaoqin ^a   Liu, Jinngjing ^a   Hou, Nali ^a,b   Bin, Tan ^a   Zhang, Yun ^a   Li, Tingyu ^a,b   Chen, Jie ^a  

^a CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b Chongqing Key Laboratory   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; PROTEIN BAX; PROTEIN BCL 2; STAT3 PROTEIN;

ANIMAL; ANIMAL BEHAVIOR; APOPTOSIS; ASTROCYTE; COCULTURE; COGNITION; GENE EXPRESSION; GENETIC TRANSDUCTION; GENETICS; HYPOXIA-ISCHEMIA, BRAIN; LEARNING; MEMORY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; NERVE CELL; NEWBORN; PSYCHOLOGY; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; ASTROCYTES; BCL-2-ASSOCIATED X PROTEIN; BEHAVIOR, ANIMAL; COCULTURE TECHNIQUES; COGNITION; GENE EXPRESSION; HYPOXIA-ISCHEMIA, BRAIN; INTERLEUKIN-6; LEARNING; MEMORY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NEURONS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANSDUCTION, GENETIC;

EID: 84954123109     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep18587     Document Type: Article

References (55)

1. Ferriero, D. M. Neonatal brain injury. N. Engl. J. Med. 351, 1985-1995 (2004).
2. Phillips, A. W., Johnston, M. V. & Fatemi, A. The potential for cell-based therapy in perinatal brain injuries. Transl. Stroke Res. 4, 137-148 (2013).
3. van Velthoven, C. T., Kavelaars, A., van Bel, F. & Heijnen, C. J. Nasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage. Pediatr. Res. 68, 419-422 (2010).
4. van Velthoven, C. T., Kavelaars, A., van Bel, F. & Heijnen, C. J. Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration. Brain Behav. Immun. 24, 387-393 (2010).
5. van Velthoven, C. T., Kavelaars, A., van Bel, F. & Heijnen, C. J. Repeated mesenchymal stem cell treatment after neonatal hypoxia-ischemia has distinct effects on formation and maturation of new neurons and oligodendrocytes leading to restoration of damage, corticospinal motor tract activity, and sensorimotor function. J. Neurosci. 30, 9603-9611 (2010).
6. van Velthoven, C. T. et al. Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke. Stroke 44, 1426-1432 (2013).
7. Aggarwal, S. & Pittenger, M. F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105, 1815-1822 (2005).
8. Kode, J. A., Mukherjee, S., Joglekar, M. V. & Hardikar, A. A. Mesenchymal stem cells: immunobiologyand role in immunomodulation and tissue regeneration. Cytotherapy 11, 377-391 (2009).
9. Chen, X. et al. Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology 22, 275-279 (2002).
10. Zhang, Y. et al. Mesenchymal stromal cell neuroprotection of hydrogen peroxide -challenged pheochromocytoma cells through reducing apoptosis and releasing cytokines. Cytotherapy 14, 954-966 (2012).
11. Kishimoto, T., Akira, S., Narazaki, M. & Taga, T. Interleukin-6 family of cytokines and gp130. Blood 86, 1243-1254 (1995).
12. Heinrich, P. C., Behrmann, I., Müller-Newen, G., Schaper, F. & Graeve, L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J. 334, 297-314 (1998).
13. Heinrich, P. C. et al. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374, 1-20 (2003).
14. Erta, M., Quintana, A. & Hidalgo, J. Interleukin-6, a major cytokine in the central nervous system. Int. J. Biol. Sci. 8, 1254-1266 (2012).
15. Spooren, A. et al. Interleukin-6, a mental cytokine. Brain Res. Rev. 67, 157-183 (2011).
16. Dilenge, M. E., Majnemer, A. & Shevell, M. I. Long-term developmental outcome of asphyxiated term neonates. J. Child Neurol. 16, 781-792 (2001).
17. Fibbe, W. E., Nauta, A. J. & Roelofs, H. Modulation of immune responses by mesenchymal stem cells. Ann. N. Y. Acad. Sci 1106, 272-278 (2007).
18. Galindo, L. T. et al. Mesenchymal stem cell therapy modulates the inflammatory response in experimental traumatic brain injury. Neurol. Res. Int. 2011, (2011).
19. Pizzi, M. et al. Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices. Mol. Cell. Neurosci. 25, 301-311 (2004).
20. Kang, M. K. & Kang, S. K. Interleukin-6 induces proliferation in adult spinal cord-derived neural progenitors via the JAK2/STAT3 pathway with EGF-induced MAPK phosphorylation. Cell Prolif. 41, 377-392 (2008).
21. Romero, J. et al. Dual role of astrocytes in perinatal asphyxia injury and neuroprotection. Neurosci. Lett. 565, 42-46 (2014).
22. Donega, V. et al. Intranasal mesenchymal stem cell treatment for neonatal brain damage: long-term cognitive and sensorimotor improvement. PloS one 8, e51253 (2013).
23. Bang, O. Y., Lee, J. S., Lee, P. H. & Lee, G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann. Neurol. 57, 874-882 (2005).
24. Woodbury, D., Schwarz, E. J., Prockop, D. J. & Black, I. B. Adult rat and human bone marrow stromal stem cells differentiate into neurons. Neurosci. Res. 61, 364-370 (2000).
25. Chen, J. et al. Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J. Neurol. Sci. 189, 49-57 (2001).
26. Chen, J. et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32, 1005-1011 (2001).
27. Leker, R. R., Lasri, V. & Chernoguz, D. Growth factors improve neurogenesis and outcome after focal cerebral ischemia. J. Neural. Transm. 116, 1397-1402 (2009).
28. Crigler, L., Robey, R. C., Asawachaicharn, A., Gaupp, D. & Phinney, D. G. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp. Neurol. 198, 54-64 (2006).
29. van Velthoven, C. T., Kavelaars, A., van Bel, F. & Heijnen, C. J. Mesenchymal stem cell transplantation changes the gene expression profile of the neonatal ischemic brain. Brain Behav. Immun. 25, 1342-1348 (2011).
30. Kishimoto, T. The biology of interleukin-6. Blood 74, 1-10 (1989).
31. De Laurentiis, A. et al. Effect of interleukin-6 and tumor necrosis factor-alpha on GABA release from mediobasal hypothalamus and posterior pituitary. Neuroimmunomodulation 7 (2000).
32. Acalovschi, D. et al. Multiple levels of regulation of the interleukin-6 system in stroke. Stroke 34, 1864-1869 (2003).
33. Li, S. J. et al. The role of TNF-α, IL-6, IL-10, and GDNF in neuronal apoptosis in neonatal rat with hypoxic-ischemic encephalopathy. Eur. Rev. Med. Pharmacol. Sci. 18, 905-909 (2014).
34. Huang, J., Upadhyay, U. M. & Tamargo, R. J. Inflammation in stroke and focal cerebral ischemia. Surg. Neurol. 66, 232-245.
35. Swartz, K. R. et al. Interleukin-6 promotes post-traumatic healing in the central nervous system. Brain Res. 896, 86-95 (2001).
36. Pekny, M. & Pekna, M. Astrocyte reactivity and reactive astrogliosis: costs and benefits. Physiol. Rev. 94, 1077-1098 (2014).
37. Dimou, L. & Gotz, M. Glial cells as progenitors and stem cells: new roles in the healthy and diseased brain. Physiol. Rev. 94, 709-737 (2014).
38. Sharma, K., Selzer, M. E. & Li, S. Scar-mediated inhibition and CSPG receptors in the CNS. Exp. Neurol. 237, 370-378 (2012).
39. Wang, X. et al. Axonal regeneration induced by blockade of glial inhibitors coupled with activation of intrinsic neuronal growth pathways. Exp. Neurol. 237, 55-69 (2012).
40. Barreto, G. E., Gonzalez, J., Torres, Y. & Morales, L. Astrocytic-neuronal crosstalk: implications for neuroprotection from brain injury. Neurosci. Res. 71, 107-113 (2011).
41. Zhang, D., Hu, X., Qian, L., O'Callaghan, J. P. & Hong, J. S. Astrogliosis in CNS pathologies: is there a role for microglia? Mol. Neurobiol. 41, 232-241 (2010).
42. Takano, T., Oberheim, N., Cotrina, M. L. & Nedergaard, M. Astrocytes and ischemic injury. Stroke; a journal of cerebral circulation 40, S8-12 (2009).
43. Greve, M. W. & Zink, B. J. Pathophysiology of traumatic brain injury. Mt. Sinai. J. Med. 76, 97-104 (2009).
44. Scheller, J., Chalaris, A., Schmidt-Arras, D. & Rose-John, S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim. Biophys. Acta. 1813, 878-888 (2011).
45. Rahaman, S. O. et al. Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells. Oncogene 21, 8404-8413 (2002).
46. Liu, Z., Qiu, Y. H., Li, B., Ma, S. H. & Peng, Y. P. Neuroprotection of interleukin-6 against NMDA-induced apoptosis and its signal-transduction mechanisms. Neurotox. Res. 19, 484-495 (2011).
47. Rice, J. E. r., Vannucci, R. C. & Brierley, J. B. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann. Neurol. 9, 131-141 (1981).
48. Bi, Y. et al. AP2alpha transcriptional activity is essential for retinoid-induced neuronal differentiation of mesenchymal stem cells. Int. J. Biochem. Cell Biol. 46, 148-160 (2014).
49. Morris, R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11, 47-60 (1984).
50. Nelson, A. J. & Vann, S. D. Mammilliothalamic tract lesions disrupt tests of visuo-spatial memory. Behav. Neurosci. 128, 494-503 (2014).
51. Zhou, X. et al. Human Umbilical Cord-Derived Mesenchymal Stem Cells Improve Learning and Memory Function in Hypoxic-Ischemic Brain-Damaged Rats via an IL-8-Mediated Secretion Mechanism Rather than Differentiation Pattern Induction. Cell Physiol. Biochem. 35, 2383-2401. (2015).
52. Bi, Y. et al. Pre-activation of retinoid signaling facilitates neuronal differentiation of mesenchymal stem cells. Development, growth & differentiation 52, 419-431 (2010).
53. He, M., Liu, J., Gu, Y., Li, T. & Chen, J. Effects of inhibiting secretion of mesenchymal stem cells originated interleukin-6 on oxygen glucose deprivation injured PC12 cells. Journal of Shanghai Jiao Tong University Medical Science 34, 1435-1447 (2014).
54. Hou, N. et al. Vitamin A deficiency impairs spatial learning and memory: the mechanism of abnormal CBP-dependent histone acetylation regulated by retinoic acid receptor alpha. Mol. Neurobiol. 51, 633-647 (2014).
55. Madrigal, J. L., Dello Russo, C., Gavrilyuk, V. & Feinstein, D. L. Effects of noradrenaline on neuronal NOS2 expression and viability. Antioxid. Redox. Signal. 8, 885-892 (2006).